Wu Carolyn M, Bergquist Peter J, Srichai Monvadi B
Department of Cardiology, MedStar Georgetown University Hospital, MedStar Washington Hospital Center, MedStar Heart and Vascular Institute, Washington, DC, 20007, USA.
Department of Radiology & Department of Radiology, Medstar Georgetown University Hospital, 3800 Reservoir Road NW, 5PHC, Washington, DC, 20007, USA.
Curr Treat Options Cardiovasc Med. 2019 Sep 5;21(10):55. doi: 10.1007/s11936-019-0756-x.
Intracardiac masses are classified as neoplastic or non-neoplastic. Prognosis varies based on the diagnosis of the mass since treatment options differ greatly. As novel imaging techniques emerge, a multimodality approach to the evaluation of intracardiac masses becomes an important part of non-invasive evaluation prior to potential surgical planning or oncological treatment. The purpose of this article is to compare the available imaging modalities-echocardiography, cardiovascular magnetic resonance, cardiac computed tomography, nuclear imaging, and emerging novel hybrid imaging techniques for future clinical applications-and to review the characteristic features seen on those modalities for the most common intracardiac masses.
心内肿物分为肿瘤性和非肿瘤性。由于治疗方案差异很大,预后因肿物的诊断而异。随着新型成像技术的出现,在潜在的手术规划或肿瘤治疗之前,采用多模态方法评估心内肿物成为无创评估的重要组成部分。本文的目的是比较现有的成像模态——超声心动图、心血管磁共振、心脏计算机断层扫描、核成像以及新兴的新型混合成像技术在未来临床应用中的情况——并回顾这些模态上最常见心内肿物的特征。